Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07452432
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 19 years
Histologically confirmed high-grade upper tract urothelial carcinoma (renal pelvis and/or ureter)
Clinical stage cT2-T4, cN0-1, M0
Planned neoadjuvant chemotherapy followed by radical nephroureterectomy
ECOG performance status 0-1
Adequate hematologic, hepatic, and renal function
Ability to provide written informed consent
Exclusion Criteria:
* Evidence of distant metastasis (M1)
Contraindication to cisplatin-based chemotherapy
Uncontrolled infection or severe comorbid medical condition
Pregnancy or breastfeeding
Any condition that, in the investigator's judgment, makes participation inappropriate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT07452432
Study Brief:
Protocol Section:
NCT07452432